EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Chimeric antigen receptor T cells in the treatment of osteosarcoma (Review)

Tong Yu, Weibo Jiang, Yang Wang, Ying Zhou, Jianhang Jiao, Minfei Wu

International Journal of Oncology · 2024

DOI: 10.3892/ijo.2024.5628 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Oncology, 2024. Verfasst von Tong Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The Second Norman Bethune Hospital of Jilin University, Changchun, Jilin 130000, P.R. China. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Osteosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 277 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma (OS) is a frequently occurring primary bone tumor, mostly affecting children, adolescents and young adults. Before 1970, surgical resection was the main treatment method for OS, but the clinical results were not promising. Subsequently, the advent of chemotherapy has improved the prognosis of patients with OS. However, there is still a high incidence of metastasis or recurrence, and chemotherapy has several side effects, thus making the 5‑year survival rate markedly low. Recently, chimeric antigen receptor T (CAR‑T) cell therapy represents an alternative immunotherapy approach with significant potential for hematologic malignancies. Nevertheless, the application of CAR‑T cells in the treatment of OS faces numerous challenges. The present review focused on the advances in the development of CAR‑T cells to improve their clinical efficacy, and discussed ways to overcome the difficulties faced by CAR T‑cell therapy for OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Chimeric AntigenOsteosarcomaBone NeoplasmsChildHumansAdolescentImmunotherapy, AdoptiveT-LymphocytesReceptors, Antigen, T-Cell

Stichwörter der Autor:innen

T cellchimeric antigen receptorchimeric antigen receptor T cell therapyimmunotherapyosteosarcoma

Substanzen

Receptors, Chimeric AntigenReceptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Department of Orthopedics, The Second Norman Bethune Hospital of Jilin University, Changchun, Jilin 130000, P.R. China.
  • Department of Operating Room, The Third Hospital of Qinhuangdao, Qinhuangdao, Hebei 066000, P.R. China.

Zitieren

APA

Yu, T., Jiang, W., Wang, Y., Zhou, Y., Jiao, J., & Wu, M. (2024). Chimeric antigen receptor T cells in the treatment of osteosarcoma (Review). International Journal of Oncology. https://doi.org/10.3892/ijo.2024.5628

Vancouver

Yu T, Jiang W, Wang Y, Zhou Y, Jiao J, Wu M. Chimeric antigen receptor T cells in the treatment of osteosarcoma (Review). International Journal of Oncology. 2024. doi:10.3892/ijo.2024.5628

BibTeX
@article{Yu2024,
  author = {Yu, Tong and Jiang, Weibo and Wang, Yang and Zhou, Ying and Jiao, Jianhang and Wu, Minfei},
  title = {Chimeric antigen receptor T cells in the treatment of osteosarcoma (Review)},
  journal = {International Journal of Oncology},
  year = {2024},
  doi = {10.3892/ijo.2024.5628}
}
Kostenlos starten →